Clayton Yates - 08 May 2025 Form 4 Insider Report for Genvor Inc (GNVR)

Signature
/s/ Dr. Clayton Yates
Issuer symbol
GNVR
Transactions as of
08 May 2025
Transactions value $
$100,000
Form type
4
Filing time
23 Jun 2025, 19:32:01 UTC
Previous filing
14 Nov 2023

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Yates Clayton Clopton Director, 10%+ Owner 1550 W HORIZON RIDGE PKWY, STE R #3040, HENDERSON /s/ Dr. Clayton Yates 23 Jun 2025 0002000242

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNVR Common Stock Award $100K +400K $0.25 400K 08 May 2025 ACT Holdings, LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Conversion of $100,000 in accrued payables due to Dr. Yates at $0.25/share. The issuance of the 400K shares to Clayton in consideration of his conversion of $100K in accrued payables, pursuant to Dr. Yates's restructured compensation package, which permits Dr. Yates to convert amounts due to him into common stock.
F2 Dr. Yates is a manager of, and may therefore be deemed to be the beneficial owner of shares held in the name of, ACT Holdings, LLC.